Site-directed mutagenesis studies and independent molecular modeling studies were combined to investigate the network of inter-residue interactions within the transmembrane region of the angiotensin AT 1a receptor. Site-directed mutagenesis was focused on residues Tyr292, Asn294, Asn295, and Asn298 in transmembrane helix 7, and the conserved Asp74 in helix 2 and other polar residues. Functional interactions between pairs of residues were evaluated by determining the effects of single and double-reciprocal mutations on agonist-induced AT 1a receptor activation. Replacement of Tyr292 by aspartate in helix 7 abolished radioligand binding to both Y292D and D74Y/Y292D mutant receptors. Reciprocal mutations of Asp74/Asn294, Ser115/Asn294, Ser252/ Asn294, and Asn298/Sen115 caused additive impairment of function, suggesting that these pairs of residues make independent contributions to AT 1a receptor activation. In contrast, mutations of the Asp74/Tyr298 pair revealed that the D74N/ N298D reciprocal mutation substantially increased the impaired inositol phosphate responses of the D74N and N298D receptors. Extensive molecular modeling yielded 3D models of the TM region of the AT 1 receptor and the mutants as well as of their complexes with angiotensin II, which were used to rationalize the possible reasons of impairing of function of some mutants. These data indicate that Asp74 and Asn298 are not optimally positioned for direct strong interaction in the resting conformation of the AT 1a receptor. Balance of interactions between residues in helix 2 (as D74) and helix 7 (as N294, N295 and N298) in the AT 1 receptors, however, has a crucial role both in determining their functional activity and levels of their expression.Keywords: angiotensin receptor type 1; G protein-coupled receptors; molecular modeling; site-directed mutagenesis , is the major effector molecule of the renin-angiotensin system. Ang II acts as a crucial regulator in the maintenance of electrolyte and cardiovascular homeostasis by binding to specific cell surface receptors in its numerous target tissues. Pharmacologic and molecular biologic studies have identified two major Ang II receptor subtypes (1,2) termed AT 1 and AT 2 receptors, both of which are heptahelical transmembrane (TM) molecules that belong to the superfamily of G-protein-coupled receptors (GPCRs). To date, the known physiologic actions of Ang II appear to be mediated by the AT 1 receptor. Agonist binding to the AT 1 receptor is believed to induce a conformational change in the receptor molecule that is transmitted to the intracellular loops by the TM helices (3,4) and serves as an initial step for signal transduction (5-7).Despite the great structural diversity in size and chemical composition of their activating ligands, all GPCRs share a common molecular architecture of seven TM a-helical domains that are linked by alternating extracellular and intracellular loops. So far, the 3D structure for only one GPCR, the photoreceptor rhodopsin, has been revealed at high resolution by X-ray cryst...